Detalhe da pesquisa
1.
CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer.
Clin Exp Med
; 23(6): 2409-2419, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495368
2.
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels.
Mol Ther Oncolytics
; 28: 46-58, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36654786
3.
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia.
Cell Death Dis
; 13(8): 671, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918330
4.
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies.
Front Immunol
; 13: 808347, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35693763
5.
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D.
Mol Ther Oncolytics
; 26: 15-26, 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35784403
6.
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis.
Nat Commun
; 13(1): 6051, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229619
7.
Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer.
Front Immunol
; 12: 660488, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326835
8.
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells.
Leukemia
; 35(5): 1380-1391, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168950
9.
PSCA is a target of chimeric antigen receptor T cells in gastric cancer.
Biomark Res
; 8: 3, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32010446
10.
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth.
Biomark Res
; 8: 19, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514352
11.
Current status and hurdles for CAR-T cell immune therapy.
Blood Sci
; 1(2): 148-155, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402809
12.
DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells.
Oncoimmunology
; 8(1): e1509173, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546945
13.
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer.
J Hematol Oncol
; 12(1): 18, 2019 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30777106
14.
Incorporation of functional elements enhances the antitumor capacity of CAR T cells.
Exp Hematol Oncol
; 6: 28, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29046826
15.
Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia.
Cell Death Dis
; 13(8): 743, 2022 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038554
16.
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells.
Oncoimmunology
; 6(3): e1284722, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405515
17.
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.
J Hematol Oncol
; 10(1): 68, 2017 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28288656
18.
Mechanisms determining the fate of hematopoietic stem cells.
Stem Cell Investig
; 2: 10, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-27358878